According to experts, some vaccines, called vectored-vaccines, use viruses compatible with the human body to deliver the DNA or RNA of the novel coronavirus inside our...
It would be a huge challenge for any country to maintain cold chain facility at a lower temperature of -70 degree or -80 degree celsius, said...
Pfizer and its partner German biotechnology firm BioNTech had last week published data that their vaccine offered 90 per cent protection from the infection as compared...
Bharat Biotech has partnered with the Indian Council of Medical Research (ICMR) for a country-made COVID-19 vaccine using the virus strain isolated by ICMR's National Institute...
Moderna’s potential COVID-19 vaccine rely on a technology called messenger RNA, which is designed to transform the body's own cells to making the vaccine
COVAXIN has been evaluated in about 1,000 subjects in Phase I and Phase II clinical trials, with promising safety and immunogenicity data
Serum Institute of India said that it had enrolled 1,600 participants in India for the late-stage trials of AstraZeneca's candidate, and also plans to seek regulatory...
The promising results of the COVID-19 vaccine trials so far give confidence that Covishield could be a realistic solution to the deadly pandemic
According to Pfizer’s spokesperson, COVID-19 vaccine candidate developed by the firm in partnership with German biotechnology company BioNTech has the potential to be an important part...
The announcement by Russia comes days after drug giant American Pfizer announced that its coronavirus vaccine was more than 90 per cent effective at protecting people...
Pharma companies around the world are testing their COVID-19 vaccine in healthy volunteers to see if the rate of COVID-19 infection among those who got the...
According to a professor at Indian Institute of Science, the scientist are currently seeking fund to start clinical research of the COVID-19 and HIV vaccines being...
